The first five years of single-cell cancer genomics and beyond

Genome Research

Volumn 25, Issue 10, 2015, Pages 1499-1507

  Navin, Nicholas E ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTAGENIC AGENT;

CANCER CELL; CANCER RESEARCH; CANCER STEM CELL; CHROMOSOME REARRANGEMENT; CIRCULATING TUMOR CELL; CLONAL EVOLUTION; CLONAL VARIATION; GENE AMPLIFICATION; GENE MUTATION; GENOMICS; HUMAN; METASTASIS; NERVE CELL PLASTICITY; NEXT GENERATION SEQUENCING; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; SEQUENCE ANALYSIS; SINGLE CELL ANALYSIS; SINGLE CELL SEQUENCING; THERAPY RESISTANCE; TUMOR MICROENVIRONMENT; ANIMAL; CYTOLOGY; GENETICS; NEOPLASM;

ANIMALS; CYTOLOGICAL TECHNIQUES; GENETIC RESEARCH; GENOMICS; HUMANS; NEOPLASMS;

EID: 84942917849     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.191098.115     Document Type: Review

References (91)

1. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al. 2014. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158: 1110-1122.
2. Adams JM, Strasser A. 2008. Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res 68: 4018-4021.
3. Alexander S, Weigelin B, Winkler F, Friedl P. 2013. Preclinical intravital microscopy of the tumour-stroma interface: invasion, metastasis, and therapy response. Curr Opin Cell Biol 25: 659-671.
4. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale AL, et al. 2013. Signatures of mutational processes in human cancer. Nature 500: 415-421.
5. Almendro V, Cheng YK, Randles A, Itzkovitz S, Marusyk A, Ametller E, Gonzalez-Farre X, Muñoz M, Russnes HG, Helland A, et al. 2014. Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. Cell Rep 6: 514-527.
6. Baca SC, Prandi D, Lawrence MS, Mosquera JM, Romanel A, Drier Y, Park K, Kitabayashi N, MacDonald TY, Ghandi M, et al. 2013. Punctuated evolution of prostate cancer genomes. Cell 153: 666-677.
7. Baslan T, Kendall J, Rodgers L, Cox H, Riggs M, Stepansky A, Troge J, Ravi K, Esposito D, Lakshmi B, et al. 2012. Genome-wide copy number analysis of single cells. Nat Protoc 7: 1024-1041.
8. Baslan T, Kendall J, Ward B, Cox H, Leotta A, Rodgers L, Riggs M, D'Italia S, Sun G, Yong M, et al. 2015. Optimizing sparse sequencing of single cells for highly multiplex copy number profiling. Genome Res 25: 714-724.
9. Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F, Vitale L, Pelleri MC, Tassani S, Piva F, et al. 2013. An estimation of the number of cells in the human body. Ann Human Biol 40: 463-471.
10. Bielas JH, Loeb LA. 2005. Mutator phenotype in cancer: timing and perspectives. Environ Mol Mutagen 45: 206-213.
11. Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA. 2006. Human cancers express a mutator phenotype. Proc Natl Acad Sci 103: 18238-18242.
12. Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, Jager M, Ponz- Sarvise M, Tiriac H, Spector MS, et al. 2015. Organoid models of human and mouse ductal pancreatic cancer. Cell 160: 324-338.
13. Burrell RA, McGranahan N, Bartek J, Swanton C. 2013. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501: 338-345.
14. Campbell LL, Polyak K. 2007. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 6: 2332-2338.
15. Clarke MF, Becker MW. 2006. Stem cells: the real culprits in cancer? Sci Am 295: 52-59.
16. Crosetto N, Bienko M, van Oudenaarden A. 2015. Spatially resolved transcriptomics and beyond. Nat Rev Genet 16: 57-66.
17. Dago AE, Stepansky A, Carlsson A, Luttgen M, Kendall J, Baslan T, Kolatkar A, Wigler M, Bethel K, Gross ME, et al. 2014. Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells. PLoS One 9: e101777.
18. de Bourcy CF, De Vlaminck I, Kanbar JN, Wang J, Gawad C, Quake SR. 2014. A quantitative comparison of single-cell whole genome amplification methods. PLoS One 9: e105585.
19. Dey SS, Kester L, Spanjaard B, Bienko M, van Oudenaarden A. 2015. Integrated genome and transcriptome sequencing of the same cell. Nat Biotechnol 33: 285-289.
20. Eirew P, Steif A, Khattra J, Ha G, Yap D, Farahani H, Gelmon K, Chia S, Mar C, Wan A, et al. 2014. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature 518: 422-426.
21. Fan HC, Fu GK, Fodor SP. 2015. Expression profiling. Combinatorial labeling of single cells for gene expression cytometry. Science 347: 1258367.
22. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
23. Francis JM, Zhang CZ, Maire CL, Jung J, Manzo VE, Adalsteinsson VA, Homer H, Haidar S, Blumenstiel B, Pedamallu CS, et al. 2014. EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing. Cancer Discov 4: 956-971.
24. Gawad C, Koh W, Quake SR. 2014. Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics. Proc Natl Acad Sci 111: 17947-17952.
25. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, et al. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366: 883-892.
26. Gotelli N, Colwell R. 2001. Quantifying biodiversity: procedures and pitfalls in the measurement and comparison of species richness. Ecol Lett 4: 379-391.
27. Greaves M, Maley CC. 2012. Clonal evolution in cancer. Nature 481: 306-313.
28. Guo H, Zhu P,WuX, Li X, WenL, Tang F. 2013. Single-cell methylome landscapes of mouse embryonic stem cells and early embryos analyzed using reduced representation bisulfite sequencing. Genome Res 23: 2126-2135.
29. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
30. Hashimshony T, Wagner F, Sher N, Yanai I. 2012. CEL-Seq: single-cell RNAseq by multiplexed linear amplification. Cell Rep 2: 666-673.
31. Heitzer E, Auer M, Gasch C, Pichler M, Ulz P, Hoffmann EM, Lax S, Waldispuehl-Geigl J, Mauermann O, Lackner C, et al. 2013. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res 73: 2965-2975.
32. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, et al. 2006. Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res 16: 1465-1479.
33. Höglund M, Gisselsson D, Hansen GB, Säll T, Mitelman F. 2002. Multivariate analysis of chromosomal imbalances in breast cancer delineates cytogenetic pathways and reveals complex relationships among imbalances. Cancer Res 62: 2675-2680.
34. Hou Y, Song L, Zhu P, Zhang B, Tao Y, Xu X, Li F,WuK, Liang J, Shao D, et al. 2012. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148: 873-885.
35. Hughes AE, Magrini V, Demeter R, Miller CA, Fulton R, Fulton LL, Eades WC, Elliott K, Heath S, Westervelt P, et al. 2014. Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing. PLoS Genet 10: e1004462.
36. Islam S, Zeisel A, Joost S, La Manno G, Zajac P, Kasper M, Lonnerberg P, Linnarsson S. 2014. Quantitative single-cell RNA-seq with unique molecular identifiers. Nat Methods 11: 163-166.
37. Jan M, Snyder TM, Corces-Zimmerman MR, Vyas P, Weissman IL, Quake SR, Majeti R. 2012. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med 4: 149ra118.
38. Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
39. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, et al. 2013. Mutational landscape and significance across 12 major cancer types. Nature 502: 333-339.
40. Lee JH, Daugharthy ER, Scheiman J, Kalhor R, Yang JL, Ferrante TC, Terry R, Jeanty SS, Li C, Amamoto R, et al. 2014. Highly multiplexed subcellular RNA sequencing in situ. Science 343: 1360-1363.
41. Leung ML, Wang Y, Waters J, Navin NE. 2015. SNES: single nucleus exome sequencing. Genome Biol 16: 55.
42. Li Y, Xu X, Song L, Hou Y, Li Z, Tsang S, Li F, Im KM,WuK,WuH, et al. 2012. Single-cell sequencing analysis characterizes common and cell-lineagespecific mutations in a muscle-invasive bladder cancer. Gigascience 1: 12.
43. Livesey FJ. 2003. Strategies for microarray analysis of limiting amounts of RNA. Brief Funct Genomic Proteomic 2: 31-36.
44. Loeb LA. 2011. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer 11: 450-457.
45. Loeb LA, Springgate CF, Battula N. 1974. Errors in DNA replication as a basis of malignant changes. Cancer Res 34: 2311-2321.
46. Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz- Gordillo P, Francis JM, Zhang CZ, Shalek AK, Satija R, et al. 2014. Wholeexome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol 32: 479-484.
47. Lovatt D, Ruble BK, Lee J, Dueck H, Kim TK, Fisher S, Francis C, Spaethling JM, Wolf JA, Grady MS, et al. 2014. Transcriptome in vivo analysis (TIVA) of spatially defined single cells in live tissue. Nat Methods 11: 190-196.
48. Macaulay IC, HaertyW, Kumar P, Li YI, Hu TX, Teng MJ, Goolam M, Saurat N, Coupland P, Shirley LM, et al. 2015. G&T-seq: parallel sequencing of single-cell genomes and transcriptomes. Nat Methods 12: 519-522.
49. Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, Tirosh I, Bialas AR, Kamitaki N, Martersteck EM, et al. 2015. Highly parallel genome- wide expression profiling of individual cells using nanoliter droplets. Cell 161: 1202-1214.
50. Merlo LMF, Pepper JW, Reid BJ, Maley CC. 2006. Cancer as an evolutionary and ecological process. Nat Rev Cancer 6: 924-935.
51. Murugaesu N, Chew SK, Swanton C. 2013. Adapting clinical paradigms to the challenges of cancer clonal evolution. Am J Pathol 182: 1962-1971.
52. Nagano T, Lubling Y, Stevens TJ, Schoenfelder S, Yaffe E, DeanW, Laue ED, Tanay A, Fraser P. 2013. Single-cell Hi-C reveals cell-to-cell variability in chromosome structure. Nature 502: 59-64.
53. Navin NE. 2014a. Cancer genomics: one cell at a time. Genome Biol 15: 452.
54. Navin NE. 2014b. Tumor evolution in response to chemotherapy: phenotype versus genotype. Cell Rep 6: 417-419.
55. Navin NE, Hicks J. 2010. Tracing the tumor lineage. Mol Oncol 4: 267-283.
56. Navin N, Krasnitz A, Rodgers L, Cook K, Meth J, Kendall J, Riggs M, Eberling Y, Troge J, Grubor V, et al. 2010. Inferring tumor progression from genomic heterogeneity. Genome Res 20: 68-80.
57. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, et al. 2011. Tumour evolution inferred by single-cell sequencing. Nature 472: 90-94.
58. Ni X, Zhuo M, Su Z, Duan J, Gao Y, Wang Z, Zong C, Bai H, Chapman AR, Zhao J, et al. 2013. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci 110: 21083-21088.
59. Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, Raine K, Jones D, Marshall J, Ramakrishna M, et al. 2012. The life history of 21 breast cancers. Cell 149: 994-1007.
60. Pardoll DM. 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12: 252-264.
61. Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, et al. 2014. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344: 1396-1401.
62. Picelli S, Faridani OR, Björklund AK, Winberg G, Sagasser S, Sandberg R. 2014. Full-length RNA-seq from single cells using Smart-seq2. Nat Protoc 9: 171-181.
63. Polyak K. 2007. Breast cancer stem cells: a case of mistaken identity? Stem Cell Rev 3: 107-109.
64. Polyak K, Weinberg RA. 2009. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
65. Potter NE, Ermini L, Papaemmanuil E, Cazzaniga G, Vijayaraghavan G, Titley I, Ford A, Campbell P, Kearney L, Greaves M. 2013. Single-cell mutational profiling and clonal phylogeny in cancer. Genome Res 23: 2115-2125.
66. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, Telli ML, Advani RH, Carlson RW, Mollick JA, et al. 2012. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One 7: e33788.
67. Ramsköld D, Luo S, Wang YC, Li R, Deng Q, Faridani OR, Daniels GA, Khrebtukova I, Loring JF, Laurent LC, et al. 2012. Full-length mRNASeq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol 30: 777-782.
68. Ruiz C, Li J, Luttgen MS, Kolatkar A, Kendall JT, Flores E, Topp Z, Samlowski WE, McClay E, Bethel K, et al. 2015. Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients. Phys Biol 12: 016008.
69. Sabouri-Ghomi M, Wu Y, Hahn K, Danuser G. 2008. Visualizing and quantifying adhesive signals. Curr Opin Cell Biol 20: 541-550.
70. Sachs N, Clevers H. 2014. Organoid cultures for the analysis of cancer phenotypes. Curr Opin Genet Dev 24: 68-73.
71. Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, et al. 2012. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486: 395-399.
72. Shipitsin M, Polyak K. 2008. The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab Invest 88: 459-463.
73. Stegle O, Teichmann SA, Marioni JC. 2015. Computational and analytical challenges in single-cell transcriptomics. Nat Rev Genet 16: 133-145.
74. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, et al. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144: 27-40.
75. Stingl J, Caldas C. 2007. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7: 791-799.
76. Suzuki A, Matsushima K, Makinoshima H, Sugano S, Kohno T, Tsuchihara K, Suzuki Y. 2015. Single-cell analysis of lung adenocarcinoma cell lines reveals diverse expression patterns of individual cells invoked by a molecular target drug treatment. Genome Biol 16: 66.
77. Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, Xu N, Wang X, Bodeau J, Tuch BB, Siddiqui A, et al. 2009. mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods 6: 377-382.
78. Ting DT, Wittner BS, Ligorio M, Vincent Jordan N, Shah AM, Miyamoto DT, Aceto N, Bersani F, Brannigan BW, Xega K, et al. 2014. Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep 8: 1905-1918.
79. Tomasson MH. 2009. Cancer stem cells: a guide for skeptics. J Cell Biochem 106: 745-749.
80. Van Loo P, Voet T. 2014. Single cell analysis of cancer genomes. Curr Opin Genet Dev 24: 82-91.
81. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al. 2010. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
82. Wang Y, Navin NE. 2015. Advances and applications of single-cell sequencing technologies. Mol Cell 58: 598-609.
83. Wang Y, Waters J, Leung ML, Unruh A, Roh W, Shi X, Chen K, Scheet P, Vattathil S, Liang H, et al. 2014. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 512: 155-160.
84. Wendl MC, Wilson RK. 2009. The theory of discovering rare variants via DNA sequencing. BMC Genomics 10: 485.
85. Wu AR, Neff NF, Kalisky T, Dalerba P, Treutlein B, Rothenberg ME, Mburu FM, Mantalas GL, Sim S, Clarke MF, et al. 2014. Quantitative assessment of single-cell RNA-sequencing methods. Nat Methods 11: 41-46.
86. Xu X, Hou Y, Yin X, Bao L, Tang A, Song L, Li F, Tsang S, Wu K, Wu H, et al. 2012. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148: 886-895.
87. Yu C, Yu J, Yao X, WuWK, Lu Y, Tang S, Li X, Bao L, Li X, Hou Y, et al. 2014. Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing. Cell Res 24: 701-712.
88. Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, Seth S, ChowCW, Cao Y, Gumbs C, et al. 2014. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346: 256-259.
89. Zhang CZ, Adalsteinsson VA, Francis J, Cornils H, Jung J, Maire C, Ligon KL, Meyerson M, Love JC. 2015a. Calibrating genomic and allelic coverage bias in single-cell sequencing. Nat Commun 6: 6822.
90. Zhang CZ, Spektor A, Cornils H, Francis JM, Jackson EK, Liu S, Meyerson M, Pellman D. 2015b. Chromothripsis from DNA damage in micronuclei. Nature 522: 179-184.
91. Zong C, Lu S, Chapman AR, Xie XS. 2012. Genome-wide detection of singlenucleotide and copy-number variations of a single human cell. Science 338: 1622-1626.